MD871Y - Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer - Google Patents

Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer Download PDF

Info

Publication number
MD871Y
MD871Y MDS20140054A MDS20140054A MD871Y MD 871 Y MD871 Y MD 871Y MD S20140054 A MDS20140054 A MD S20140054A MD S20140054 A MDS20140054 A MD S20140054A MD 871 Y MD871 Y MD 871Y
Authority
MD
Moldova
Prior art keywords
radiotherapy
prophylaxis
patients
breast cancer
chemotherapy
Prior art date
Application number
MDS20140054A
Other languages
Moldavian (mo)
Romanian (ro)
Russian (ru)
Inventor
Simona CHIABURU
Ion Mereuţă
Victor Cernat
Original Assignee
Simona CHIABURU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simona CHIABURU filed Critical Simona CHIABURU
Priority to MDS20140054A priority Critical patent/MD871Z/en
Publication of MD871Y publication Critical patent/MD871Y/en
Publication of MD871Z publication Critical patent/MD871Z/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, particularly to oncology and may be used for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer.According to the invention, the claimed method consists in that it is administered 200 ml of a mixture based on dandelion root and calendula vegetal part tincture, taken in the ratio of 1:1, and nanodiamonds of 4…10 nm, in a concentration of 10-9…10-10 g/L, per os, twice a day, 20 minutes before a meal, concomitantly, once a day is administered 20 ml of a mixture based on amaranth and castor oil, taken in the ratio of 1:1, and nanodiamonds of 4…10 nm, in a concentration of 10-9…10-10 g/L, per os, 20 minutes before a meal, 5 days before the radiotherapy or chemotherapy treatment, the course of treatment is 20…25 days.
MDS20140054A 2014-04-18 2014-04-18 Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer MD871Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20140054A MD871Z (en) 2014-04-18 2014-04-18 Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20140054A MD871Z (en) 2014-04-18 2014-04-18 Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer

Publications (2)

Publication Number Publication Date
MD871Y true MD871Y (en) 2015-01-31
MD871Z MD871Z (en) 2015-09-30

Family

ID=52440959

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20140054A MD871Z (en) 2014-04-18 2014-04-18 Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer

Country Status (1)

Country Link
MD (1) MD871Z (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD482G2 (en) * 1995-12-29 1997-05-31 Firma Svetskii & Co Continuous acted mixer
RU2197977C2 (en) * 2001-04-17 2003-02-10 Дмитриенко Николай Васильевич Pumpkin seed oil eliciting anti-inflammatory, antiulcerous and hepatoprotective effect and method of its preparing
EA201001000A1 (en) * 2010-04-19 2011-10-31 Алмагуль Тулеуовна Маншарипова ANTIOXIDANT MEANS OIL BALSAM "JEWELAX"
  • 2014

Also Published As

Publication number Publication date
MD871Z (en) 2015-09-30

Similar Documents

Publication Publication Date Title
PH12018500097A1 (en) Combination of pd-1 antagonist with an egfr inhibitor
MX2016011810A (en) Pharmaceutical compositions of therapeutically active compounds.
MX2017006938A (en) Combination therapy for treatment of cancer.
MX2019003173A (en) Combination therapy with controlled-release cnp agonists.
MX2022009155A (en) Novel polymeric hgh prodrugs.
CL2019001586A1 (en) Insulin containing pharmaceutical compositions.
TW201613578A (en) Pharmaceutical combinations
EA201592003A1 (en) MICRO SUPPLEMENTS FOR IMMUNITY
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
PH12016502352A1 (en) Pharmaceutical composition
PH12015502351A1 (en) Herbal compositions for treating pain and skin disorders
PH12020550462A1 (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same
PH12016501371A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
PH12020500096A1 (en) Therapeutic combination of a third generation egfr tyrosine kinase inhibitor and a raf inhibitor
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12018500450A1 (en) Immunity enhancing agent for cancer by allergin-1 antagonist
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
BR112017007364A2 (en) pharmaceutical composition for use in the treatment or prevention of vitamin and mineral deficiencies in patients who have undergone gastric bypass surgery
MD871Y (en) Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer
PL420267A1 (en) Polyporoid mushroom extract, a composition containing this extract and its use
MX2017013668A (en) Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer.
PL413830A1 (en) Lactoferrin with manganese ions complex, method for obtaining it, application of the complex and pharmaceutical composition containing the complex of lactoferrin and manganese ions
MX2018015240A (en) Compositions comprising timolol and their use in the treatment of rosacea by topical administration.
MD772Y (en) Method for treating precancerous conditions and noninvasive urinary bladder cancer
MX2019003368A (en) Anti-cancer agents and preparation thereof.

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4Y Short-term patent definitely lapsed due to non-payment of fees